John Friedman is a founder and Senior Advisor at Gore Range Capital. John has been the Founding and Managing Partner of Easton Capital Investment Group, a venture capital firm with a focus in healthcare and life sciences, for the past twenty years.
Prior to Easton Capital, John founded and led Security Pacific Capital Investors, a private equity fund geared towards expansion financings and recapitalizations. John was a Managing Director and Partner at E.M. Warburg, Pincus & Co., Inc., where he spent more than eight years. John also co-founded Comverse Technology, which grew to a revenue run rate in excess of $1 billion and a market capitalization of more than $12 billion. John started his career as an attorney with Sullivan and Cromwell.
During his career John has invested in more than 100 transactions across multiple sectors, including healthcare and technology. He previously served on the boards of Claret Medical, Conor Medsystems, Acorda (NASDAQ: ACOR), bluebird bio (NASDAQ: BLUE), and Cardiovascular System (NASDAQ: CSII), among others. In each case, he had been a founding, lead, or co-lead investor in that company.
Throughout his career John has been heavily involved with the New York medical science community. He previously served as Chairman of the Columbia University Medical Center’s Health Sciences Advisory Council and Co-Chairman of the President's Council at the Cold Spring Harbor Laboratory.
John is a devoted art lover and supporter of emerging artists. In addition to his role as a member of the Board of Trustees of the New Museum and the SculptureCenter, John serves as a mentor to Master of Fine Arts students in the tri-state area. John obtained his B.A. from Yale College (phi beta kappa and magna cum laude) and J.D. from Yale Law School.